Free Trial
NASDAQ:AVGR

Avinger (AVGR) Stock Price, News & Analysis

Avinger logo
$0.47 0.00 (0.00%)
As of 05/1/2025

About Avinger Stock (NASDAQ:AVGR)

Key Stats

Today's Range
$0.47
$0.47
50-Day Range
$0.47
$0.47
52-Week Range
$0.36
$4.15
Volume
N/A
Average Volume
1.06 million shs
Market Capitalization
$1.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Stock News Headlines

Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.
See More Headlines

AVGR Stock Analysis - Frequently Asked Questions

Avinger's stock was trading at $0.8180 at the beginning of 2025. Since then, AVGR shares have decreased by 42.1% and is now trading at $0.4740.
View the best growth stocks for 2025 here
.

Avinger, Inc. (NASDAQ:AVGR) announced its quarterly earnings data on Thursday, November, 7th. The medical device company reported ($1.82) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.03) by $0.21. The medical device company had revenue of $1.65 million for the quarter, compared to the consensus estimate of $1.60 million. Avinger had a negative trailing twelve-month return on equity of 5,527.11% and a negative net margin of 261.06%.
Read the conference call transcript
.

Shares of Avinger reverse split on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Avinger (AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avinger investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), GE Aerospace (GE) and Broadcom (AVGO).

Company Calendar

Last Earnings
11/07/2024
Today
5/02/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AVGR
Employees
70
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,320,000.00
Net Margins
-261.06%
Pretax Margin
-256.25%

Debt

Sales & Book Value

Annual Sales
$7.26 million
Price / Cash Flow
N/A
Book Value
($4.53) per share
Price / Book
-0.10

Miscellaneous

Free Float
1,893,000
Market Cap
$1.57 million
Optionable
Not Optionable
Beta
1.09

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:AVGR) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners